HCM 305 Managed Care Plan for Hepatitis A in North

HCM 305 Managed Care Plan for Hepatitis A in North America

The primary theme of the paper is HCM 305 Managed Care Plan for Hepatitis A in North America in which you are required to emphasize its aspects in detail. The cost of the paper starts from $99 and it has been purchased and rated 4.9 points on the scale of 5 points by the students. To gain deeper insights into the paper and achieve fresh information, kindly contact our support.

HCM 305 Managed Care Plan for Hepatitis A in North America

INSTRUCTIONS:
Please see the attached directions. There is also a 2 page brochure requirement, please let me know how to proceed with that thank you. Based on: HCM305_PortfolioProspectusWorksheet.docx HCM305 Health and Disease Portfolio Project: Prospectus Planning Worksheet 1. Disease: 2. Cause(s): 3. Symptoms: 4. Diagnostic Process/Testing: 5. Current Mode(s) of Treatment: 6. Prognosis for Current Mode(s) of Treatment: 7. Costs associated with current diagnostics and treatment: 8. Your Novel Plan for Treatment: Note: This plan may be based on recent articles in the literature, alternative medical approaches, former modes of treatment, or may be a new treatment based on your personal analysis. 9. Projected costs of your Planned Treatment: Note: These figures can merely be estimates of costs, but the important aspect of this section is to determine if the benefits of your plan either reduce cost, recovery time, side-effect or some other factor. The question being asked is: Why should we adopt your idea? 10. Your updated Bibliography (with your 10 original sources, plus any additional papers you may have found):
CONTENT:
Managed Care Plan for Hepatitis A in North AmericaKelly SheltonHCM 3051/28/13 IntroductionThis project contains a discussion on hepatitis A with regard to its causes, symptoms, and diagnostic process. In addition, there is the current mode of hepatitis treatment, Prognosis for Current Mode(s) of Treatment, costs associated with current diagnostics and treatment, Novel Plan for Treating Hepatitis A, and the projected costs of the Novel Plan for Treating Hepatitis A. Moreover, contains the prospectus planning worksheet, annotated bibliography of the sources used in the discussion as well as the conclusion of the discussion. Hepatitis A is a serious disease, which affects mainly the livers of the patients. It infects the cells of the liver and causes inflammation. In most cases, majority of the victims of this disease get hospitalized when the effects are at a severe stage. In such conditions, victims may die if not given due care. The disease, which is highly contagious, is believed to be spreading at a faster rate not only in North America but also around the globe (CDC, 2012). Although it is widely believed that there is no reliable cure for this ailment, preventive mechanisms such as immunization and vaccinations are widely employed to curb the severity of the diseases. Notwithstanding the latest series of disease outbreaks in North America, the rates of Hepatitis A have been constant since 1984. Additionally, the rates can be comparable to those reported in the United States during the years of 1960s and 1970s (Berger, 2011). The American liver foundation notes that the recurring increases in hepatitis A come about in every 10 years in America, but in between the outbreaks, the relatively high rates continue to be manifested. Within North America and United States in general, each state, community and county could be considered having low, intermediate or high rates of hepatitis A on the grounds of epidemiological characteristi...
100% Plagiarism Free & Custom Written, Tailored to your instructions